henry schein investor relations2021 winnebago revel accessories

These . Facts - hide this feature box title! Investor Relations. In the last-reported quarter, the company's earnings of $1.07 . The Investor Relations website contains information about Henry Schein's business for stockholders, potential investors, and financial analysts. Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. MELVILLE, N.Y., January 05, 2022 -- ( BUSINESS WIRE )--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners . Please go ahead, Carolynne. A transfer to a new job is one way to build diverse skills and experiences. ET. Henry Schein, Inc. HSIC is scheduled to report first-quarter 2022 results on May 3, before market open. MELVILLE, N.Y., May 18, 2022 -- ( BUSINESS WIRE )--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners . 2021 Guidance. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Contacts. About 50% of revenue comes from dental, 27% from animal health, 20% from medical, and 3% from technology and value-added services. Henry Schein, Inc. HSIC is scheduled to report first-quarter 2021 results on May 4, before market open. Download the Envista Investor Presentation. . We have a legacy of success built upon the proven Envista Business System methodology, an experienced leadership team, and a culture of Customer Centricity, Innovation, Respect, Continuous Improvement, and Leadership. Steven Paladino Executive Vice President and CFO steven.paladino@henryschein.com (631) 843-5500 or Carolynne Borders Vice President, Investor Relations carolynne.borders@henryschein.com . Henry Schein has raised the guidance for 2021 adjusted earnings per share from continuing operations, which is now expected to be in the range of $4.27 to $4.35, reflecting growth . The planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice will be named Covetrus. Investor Relations Henry Schein Inc - Stock Chart HSIC Morningstar Rating Rating as of Jun 3, 2022. Contacts. In this role, Graham will be responsible for driving Henry Schein's strategic communications with institutional investors and the securities analyst community as well as providing executive oversight from . May 3, 2022 3:30 AM PDT. MELVILLE, N.Y., May 05, 2022--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the UBS Global Healthcare Conference on May 24, 2022, at 2:00 p . This excludes the nonrecurring $18.1 million impairment cha -- charge that we recorded in . Contacts. Media. Henry Schein One launched a new era of integrated dental technology that works as one by joining the market-leading dental software and services of Henry Schein, Inc. with those of Internet Brands. Carolynne received a Bachelor of Science Degree degree . Quote Chart Stock Analysis News Price vs Fair Value . In Business. MELVILLE, N.Y., September 15, 2021--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer.In this role, Graham will be responsible for driving Henry Schein's . Our customers are managing increasingly complex businesses and choose a relationship with Patterson to help them handle the challenges of today and the opportunities of the future. Henry Schein is a worldwide distributor of medical, dental supplies including vaccines, pharmaceutical products, financial services and equipment. Career Opportunities. For 2022, we expect EPS attributable to Henry Schein will be in a range of $4.75 to $4.91, reflecting growth of 7% to 10% compared with our 2021 GAAP diluted EPS of $4.45 and growth of 5% to 9%. Vice President, Investor Relations and Strategic Financial Project Officer. . Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. Investor Relations . So if you go back to the second quarter of 2019, you will see that Henry Schein's worldwide internal sales growth in local currencies increased by 15.2% in 2021, again, compared to 2019. [Operator Instructions] I would now like to introduce your host for today's call, Graham Stanley, Henry Schein's Vice President of Investor Relations and Strategic Financial Project Officer. With an IR career spanning some 20 years, Borders joins the company from SMSC, a semiconductor design firm that was acquired by Microchip in August 2012. Contacts. Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, has appointed Graham Stanley as vice-president of Investor Relations and Strategic Financial Project Officer. The year-over-year uptick . Vice President, Global . Henry Schein, Inc. will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. North American internal sales in local currencies declined 0.7%, which included. Good morning, ladies and gentlemen, and welcome to the Henry Schein First Quarter 2022 Earnings Conference Call. Henry Schein, the world's leading supplier of dental, medical and animal healthcare products and services, has appointed Carolynne Borders as vice president of investor relations. Our Company. The Investor Relations website contains information about Henry Schein's business for stockholders, potential investors, and financial analysts. Carolynne Borders, Henry Schein's vice president of investor relations. MELVILLE, N.Y., May 18, 2022--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to . Investor Relations Carolynne.borders@henryschein.com . Contacts. 300,000+ . Envista 2021 Annual Report. Henry Schein reported net sales of $3.18 billion in the first quarter, up 8.7% year over year. graham.stanley@henryschein.com. Career Opportunities. Our Company. Our Company. ET. In Business. Henry Schein, Inc. announced that it will present at three virtual investor conferences in June. Total first-quarter 2022 net sales of $3.2 billion up 8.7% compared with first . Steven Paladino Executive Vice President and CFO steven.paladino@henryschein.com (631) 843-5500 Investor Relations 631-390-8105 investor@henryschein.com Media: Ann Marie Gothard Vice . For shareholder inquiries, including requests for quarterly and annual reports, contact Henry Schein's Investor Relations department at: Graham Stanley Phone: 1-631-843-5963 Vice President, Investor Relations and Strategic Financial Project Officer E-mail: Graham.Stanley@henryschein.com. MELVILLE, N.Y., March 4, 2019 /PRNewswire/ -- Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, today announced it has completed the acquisition of North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than . 07, 2019, 10:00 a.m. 90 YEARS. 2021 Guidance. Ann Marie Gothard Vice President, Corporate Media Relations [email protected] 631-390-8169. 300,000+ (631) 843-5500 or Carolynne Borders Vice President, Investor Relations carolynne.borders . Henry Schein is a worldwide distributor of medical, dental supplies including vaccines, pharmaceutical products, financial services and equipment. Moving on, GAAP net income from continuing operations attributable to Henry Schein for the third quarter of 2021 was $162.3 million or $1.15 per diluted share and included a gain on sale of an. Current Team Schein Members. Henry Schein also offers practice management products that include software products, technical, financial, and educational services. I'll note that this 5.0% quarterly growth rate is among the highest that we've recorded at Henry Schein since 2017. Investors: Steven Paladino Executive Vice President and CFO steven.paladino@henryschein.com (631) 843-5500 Investor Relations 631-390-8105 investor@henryschein.com Media: Ann Marie . Nearly 22,000. Provided by Business Wire. Henry Schein (NASDAQ: HSIC) Q1 2019 Earnings Call May. In this role, Mr Stanley will be responsible for driving Henry Schein's strategic communications with . Vice President, Investor Relations and Strategic Financial Project Officer graham.stanley@henryschein.com (631) 843-5963 Media Ann Marie Gothard Vice President, Global Corporate Media Relations annmarie.gothard@henryschein.com (631) 390-8169 Source: Henry Schein, Inc. More in Investor Relations Investor Presentations; ePlus CEO Mark Marron featured in martinwolf Executive Perspective; About Us. Carolynne Borders is a Vice President, Investor Relations at Henry Schein based in Melville, New York. In the last reported quarter, the company's earnings of $1.00 . Investor Relations. Menu. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings and public conference calls and webcasts. . The metric beat the Zacks Consensus Estimate by 1.5%. . Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as . Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. It is our policy to promote from within whenever possible. Ever since then, we have pursued the ideal of "doing well by doing good." This compares with the prior . Investors Ronald N. South Senior Vice President and Chief Financial Officer ronald.south@henryschein.com (631) 845-2802 Graham Stanley Vice President, Investor Relations and Strategic . About Henry Schein; . This website contains, and has materials that contain, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of . . This compares to earnings of $1.24 per share a year ago. About Henry Schein Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. 300,000+ Products. Contacts. Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. Please go ahead, Carolynne. Previously, Carolynne was a Senior Director, Corporate Communications at Kongsberg and also held positions at Financial Relations Board. EEO Statement Pay Transparency Policy Statement Last year, the company earned $501 million, or $5.96 a share, on sales of $10.6 billion; it is expected to earn $6.63 a share in 2016. The Investor Relations website contains information about Henry Schein's business for stockholders, potential investors, and financial analysts. A high-level overview of Henry Schein, Inc. (HSIC) stock. Henry Schein operates through a centralized and automated distribution network with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock as well as more than 180,000 additional products available as special-order items. Patterson Companies is committed to bringing the most comprehensive suite of products, workflow solutions and customer support to the dental and animal health markets. Henry Schein to webcast fourth quarter and full-year 2021 conference call on February 15, 2022. . Moving on, our GAAP net income from continuing operations attributable to Henry Schein for the first quarter of 2021 was $166.0 million or $1.16 per diluted share. The company recently spun off its animal health business . Corporate. Chief Executive Officer, Strategic Business Group. Henry Schein has raised the guidance for 2021 adjusted earnings per share from continuing operations, which is now expected to be in the range of $4.27 to $4.35, reflecting growth . Investor Relations and Strategic Financial Project Officer graham.stanley . Ann Marie Gothard. Acting as a trusted advisor, an extension of their team, a trainer . Mr. Brous joined Henry Schein, Inc. in 2002, and is currently Chief Executive Officer, Strategic Business Group, which includes the Company's manufacturing and service-based endodontic, orthodontic, and other health care businesses. About Henry Schein; . (631) 843-5963. Henry Schein ( HSIC-0.05%) Q4 . Carolynne Borders-- Vice President of Investor Relations . ePlus investor relations, including stock and financial information, press releases, and leadership. Investor Relations graham.stanley@henryschein.com (631) 843-5963 Media: . Steven Paladino Executive Vice President and CFO steven.paladino@henryschein.com (631) 843-5500 Investor Relations 631-390-8105 investor@henryschein.com Media: Ann Marie Gothard Vice . MELVILLE, N.Y., September 15, 2021--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer.In this role, Graham will be responsible for driving Henry Schein's . 21,600+ Team Schein Members. An important part of the Henry Schein philosophy is to offer Team Schein Members the opportunity to grow with Henry Schein. MELVILLE, N.Y., April 04, 2022--Henry Schein announces retirement of Chief Administrative Officer and appoints Chief Operating Officer, effective July 1, 2022. This compares with the prior . For shareholder inquiries, including requests for quarterly and annual reports, contact Henry Schein's Investor Relations department at: Graham Stanley, Vice President, Investor Relations and Strategic Financial Project Officer Phone: 1-631-843-5963 E-mail: Graham.Stanley@henryschein.com or investor@henryschein.com Henry Schein is a worldwide distributor of medical and dental supplies including vaccines, pharmaceuticals, financial services and equipment. Investor Relations and Strategic Financial Project Officer . Our amortization of acquired intangibles for Q4 2020 was $25.3 million pre-tax or $0.11 per diluted share. ePlus inc. is listed on NASDAQ Global Markets . Henry Schein, Inc. (NASDAQ:NASDAQ:HSIC) Q1 2022 Earnings Conference Call May 3, 2022, 10:00 AM ET Company Participants Stanley Bergman - Chairman and Chief Executive Officer Ronald South -. 90 YEARS. Steven Paladino Executive Vice President and CFO steven.paladino@henryschein.com (631) 843-5500 or Carolynne Borders Vice President, Investor Relations carolynne.borders@henryschein.com . Please go ahead, Graham. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than . Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as . With an IR career spanning some 20 years, Borders joins the company from SMSC, a semiconductor design firm that was acquired by Microchip in August 2012. MELVILLE, N.Y.Henry Schein has appointed Graham Stanley as vice president of investor relations and strategic financial project officer. Menu. Career Opportunities. Henry Schein (HSIC) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.21 per share. The History of Henry Schein In 1932, at the height of the Depression, a pharmacist named Henry Schein started our company with the belief that we can fulfill our responsibilities as a corporate citizen by giving back to the communities we serve. 21,600+ Team Schein Members. 90 YEARS. The Last 12 Months Of Insider Transactions At Henry Schein Over the last year, we can see that the biggest insider sale was by the Executive VP, Steven Paladino, for US$1.8m worth of shares, at. Apr 27, 2021 11:53AM EDT. Apr 27, 2022 9:01AM EDT. We are. Henry Schein Announces Participation in Investor Conferences in June. Revenues in Detail. Carolynne Borders, Henry Schein's vice president of investor relations. Henry Schein, the world's leading supplier of dental, medical and animal healthcare products and services, has appointed Carolynne Borders as vice president of investor relations. Graham Stanley. Investor Relations. Moving on, our GAAP net income from continuing operations attributable to Henry Schein for the first quarter of 2021 was $166.0 million or $1.16 per diluted share. Headquartered in American Fork, Utah, Henry Schein One is the world's largest dental software and services company. Henry Schein Reports Record First-Quarter 2022 Financial Results. Henry Schein, Inc. (NASDAQ:NASDAQ:HSIC) Q1 2021 Results Conference Call May 04, 2021 10:00 AM ET Company Participants Carolynne Borders - VP, IR Stanley Bergman - Chairman and CEO Steven. A replay of Henry Schein's presentation will be available on the Investor Presentations section of the Henry Schein website beginning May 19, 2022, and will be available for a period of up to . In Business. Vice President, Investor Relations at Henry Schein. Team Schein Members. . Vice President of Investor Relations [email protected] 407 761 8172.